Originally Posted by Bwana:
Once again, don't come in this thread with some kind of political agenda, or you will be shown the door. If you want to go that route, there is a thread about this in DC.
Originally Posted by Dartgod:
People, there is a lot of good information in this thread, let's try to keep the petty bickering to a minimum.
We all have varying opinions about the impact of this, the numbers, etc. We will all never agree with each other. But we can all keep it civil.
Thanks!
Click here for the original OP:
Spoiler!
Apparently the CoronaVirus can survive on a inanimate objects, such as door knobs, for 9 days.
California coronavirus case could be first spread within U.S. community, CDC says
By SOUMYA KARLAMANGLA, JACLYN COSGROVE
FEB. 26, 2020 8:04 PM
The Centers for Disease Control and Prevention is investigating what could be the first case of novel coronavirus in the United States involving a patient in California who neither recently traveled out of the country nor was in contact with someone who did.
“At this time, the patient’s exposure is unknown. It’s possible this could be an instance of community spread of COVID-19, which would be the first time this has happened in the United States,” the CDC said in a statement. “Community spread means spread of an illness for which the source of infection is unknown. It’s also possible, however, that the patient may have been exposed to a returned traveler who was infected.”
The individual is a resident of Solano County and is receiving medical care in Sacramento County, according to the state Department of Public Health.
The CDC said the “case was detected through the U.S. public health system — picked up by astute clinicians.”
Officials at UC Davis Medical Center expanded on what the federal agency might have meant by that in an email sent Wednesday, as reported by the Davis Enterprise newspaper.
The patient arrived at UC Davis Medical Center from another hospital Feb. 19 and “had already been intubated, was on a ventilator, and given droplet protection orders because of an undiagnosed and suspected viral condition,” according to an email sent by UC Davis officials that was obtained by the Davis Enterprise.
The staff at UC Davis requested COVID-19 testing by the CDC, but because the patient didn’t fit the CDC’s existing criteria for the virus, a test wasn’t immediately administered, according to the email. The CDC then ordered the test Sunday, and results were announced Wednesday. Hospital administrators reportedly said in the email that despite these issues, there has been minimal exposure at the hospital because of safety protocols they have in place.
A UC Davis Health spokesperson declined Wednesday evening to share the email with The Times.
Since Feb. 2, more than 8,400 returning travelers from China have entered California, according to the state health department. They have been advised to self-quarantine for 14 days and limit interactions with others as much as possible, officials said.
“This is a new virus, and while we are still learning about it, there is a lot we already know,” Dr. Sonia Angell, director of the California Department of Public Health, said in a statement. “We have been anticipating the potential for such a case in the U.S., and given our close familial, social and business relationships with China, it is not unexpected that the first case in the U.S. would be in California.”
It is not clear how the person became infected, but public health workers could not identify any contacts with people who had traveled to China or other areas where the virus is widespread. That raises concern that the virus is spreading in the United States, creating a challenge for public health officials, experts say.
“It’s the first signal that we could be having silent transmission in the community,” said Lawrence Gostin, director of the World Health Organization Collaborating Center on National and Global Health Law. “It probably means there are many more cases out there, and it probably means this individual has infected others, and now it’s a race to try to find out who that person has infected.”
On Tuesday, the CDC offered its most serious warning to date that the United States should expect and prepare for the coronavirus to become a more widespread health issue.
“Ultimately, we expect we will see coronavirus spread in this country,” said Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases. “It’s not so much a question of if, but a question of when.”
According to the CDC’s latest count Wednesday morning, 59 U.S. residents have tested positive for the new strain of coronavirus — 42 of whom are repatriated citizens from a Diamond Princess cruise. That number has grown by two since Messonnier’s last count Tuesday, although the CDC was not immediately available to offer details on the additional cases.
More than 82,000 cases of coronavirus have been reported globally, and more than 2,700 people have died, with the majority in mainland China, the epicenter of the outbreak.
But public health leaders have repeatedly reminded residents that the health risk from the novel coronavirus to the general public remains low.
“While COVID-19 has a high transmission rate, it has a low mortality rate,” the state Department of Public Health said in a statement Wednesday. “From the international data we have, of those who have tested positive for COVID-19, approximately 80% do not exhibit symptoms that would require hospitalization. There have been no confirmed deaths related to COVID-19 in the United States to date.”
CDC officials have also warned that although the virus is likely to spread in U.S. communities, the flu still poses a greater risk.
Gostin said the news of potential silent transmission does not eliminate the possibility of containing the virus in the U.S. and preventing an outbreak.
“There are few enough cases that we should at least try,” he said. “Most of us are not optimistic that that will be successful, but we’re still in the position to try.”
Originally Posted by htismaqe:
Besides Pfizer and Moderna, any other news?
AZ is going to run a new trial to test the efficacy of their half dose scheme. If it holds up, they shouldn't be too far behind in rolling out the vaccine. Right now a lot of the planned vaccine schedule is based on having Pfizer and Moderna. [Reply]
Originally Posted by Indian Chief:
AZ is going to run a new trial to test the efficacy of their half dose scheme. If it holds up, they shouldn't be too far behind in rolling out the vaccine. Right now a lot of the planned vaccine schedule is based on having Pfizer and Moderna.
Originally Posted by htismaqe:
Besides Pfizer and Moderna, any other news?
Not really. JNJ started their single dose trial in July. I thought we'd hear something by now but all they've announced is starting a new dual dose trial
Htis, it's adenovirus based for the Oxford/AZ [Reply]
Originally Posted by ChiliConCarnage:
Not really. JNJ started their single dose trial in July. I thought we'd hear something by now but all they've announced is starting a new dual dose trial
Htis, it's adenovirus based for the Oxford/AZ
Ah, the AZ = Oxford. Thanks. That's really the one I'm waiting for.
I know, I know. mRNA is "safe". I'm not keen on being a trial for anything that new. That's just me. :-) [Reply]
Originally Posted by 'Hamas' Jenkins:
mRNA-based therapies, which have been in development for anticancer treatment for some time now, have never demonstrated severe safety issues, nor have any of the major vaccine candidates at pre-specified reviews.
People are going to screw up the science of all this, because that's what the public does. A patient somewhere will have an adverse effect and it will be blown way, way, way out of proportion (like the transverse myelitis non-issue) by bad-faith actors and/or idiots.
If you ever have the time, you should download the VAERS data from the FDA website. The events that get reported are overwhelmingly asinine.
I'm with you. My concern isn't rooted in the vaccine development or the science but rather COVID itself. I don't expect any issues and I agree with you that I haven't seen anything in the data to give me major pause. However what we don't know about this virus far exceeds what we do know. [Reply]
Originally Posted by Indian Chief:
I'm with you. My concern isn't rooted in the vaccine development or the science but rather COVID itself. I don't expect any issues and I agree with you that I haven't seen anything in the data to give me major pause. However what we don't know about this virus far exceeds what we do know.
We don't know a lot, but we've also learned more about this virus than any other in history over such a short timespan. There will be long-term consequences of this virus that we won't know for some time, you are absolutely correct in that. What I do know is that if I can administer a highly-efficacious prophylactic for a disease that can cause severe coagulopathies and respiratory distress/collapse to further prevent its spread, I'm going to do it.
For all the tragedy of 2020, we are on the precipice of a wonderful scientific achievement. [Reply]
Originally Posted by petegz28:
Let me repeat what I said, the UK has approved Pfizer and it is rolling out next week. What are we waiting on?
How am I a moron when I ask about Pfizer and you tell me about Moderna?
Nonetheless you didn't answer any question. You just gave dates for approval.
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
Originally Posted by 'Hamas' Jenkins:
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
Any of this was freely available on Google, but you'd rather bitch than spend five seconds in a search bar.
And we are waiting until then why? That's not bitching that's asking why the UK is doing things a full 1-2 weeks ahead of us? But you'd rather be a dick so whatever. [Reply]
Originally Posted by petegz28:
And we are waiting until then why? That's not bitching that's asking why the UK is doing things a full 1-2 weeks ahead of us? But you'd rather be a dick so whatever.
Because. it. takes. time. to. review. data.
The US is going to have access to both vaccines faster than the EU. The US will be a few days behind the UK only for the Pfizer vaccine only. Demand still far outpaces supply, which is why there is a tiered distribution schedule. If you'd like to find articles critical of the speed of the UK's approval, you won't have a problem, trust me.
You either don't understand the process, or you're just coming up with reasons to complain. If someone told you in April that the vaccine would be available for high-risk groups on December 16th, but one other country may have it on December 12th, would you really have complained? I mean, for fuck's sake. [Reply]
I’m guessing with vaccines and infected immunity we’ll continue to see this slow thru the end of January. There’s light at the end of the tunnel for sure [Reply]
